Larvol Delta - A-Study-to-Test-Different-Doses-of-BI-1701963-Alone-and-Combined-With-Trametinib-in-Patients-With-Different-Types-of-Advanced-Cancer-Solid-Tumours-With-KRAS-Mutation

BI 1701963 - Boehringer Ingelheim

Mekinist (trametinib) - Novartis, BeOne Medicines

http://clinicaltrials.gov/ct2/show/NCT04111458

Sep 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next